⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ALK Inhibitor in Metastatic Colorectal Cancer With ALK Mutation.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: ALK Inhibitor in Metastatic Colorectal Cancer With ALK Mutation.

Official Title: ALK Inhibitor in Metastatic Colorectal Cancer With ALK Mutation.

Study ID: NCT03792568

Interventions

ALK Inhibitor

Study Description

Brief Summary: This clinical trial aims to evaluate the efficacy, safety of ALK inhibitor in Metastatic Colorectal Cancer Patients with ALK mutation.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Shanghai Changzheng Hospital, Shanghai, Shanghai, China

Shanghai Changzheng Hospital, Shanghai, Shanghai, China

Shanghai Changzheng Hospital, Shanghai, Shanghai, China

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: